ISG15 and nasopharyngeal carcinoma: ISG15 overexpression in pancreatic cancer cells has been shown to confer resistance to gemcitabine (101), while ectopic expression in NPC cells reduced cell sensitivity to radiation and cisplatin treatment (102).